ZMapp, 'modern techniques' too late to save doctor
This article was originally published in Scrip
Executive Summary
The death of a doctor who was being treated for Ebola in the US with the best of what medical care has to offer, including the hard-to-obtain experimental drug ZMapp, was a stark reminder that in the very advanced stages, even the most modern techniques are not enough to save a patient's life when they reach a critical threshold, said Dr Jeff Gold, chancellor of the University of Nebraska Medical Center (UNMC) in Omaha.